Skip to content

An observational study on the effects of electroacupuncture on brain function changes in patients with polycystic ovary syndrome

An observational study on the effects of electroacupuncture on brain function changes in patients with polycystic ovary syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026001559
Enrollment
Unknown
Registered
2026-06-20
Start date
2026-04-01
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

PCOS

Interventions

Untreated PCOS:No intervention measures
The PCOS group after electroacupuncture treatment:No intervention measures

Sponsors

Renmin Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 40 Years

Inclusion criteria

Inclusion criteria: Healthy control group (HC) 1) Age 18-40 years old, female; 2) BMI 18.5-28.0 kg/m², matched with the PCOS group; 3) Regular menstrual cycle (21-35 days), without menstrual disorders, amenorrhea, etc.; 4) No clinical manifestations of hyperandrogenism (such as hirsutism, acne, seborrheic dermatitis, etc.); 5) No organic diseases of endocrine, metabolism, nervous system, heart, liver, kidney, etc. in the past 3 months; 6) No use of any drugs affecting nerves, endocrine, metabolism in the past 3 months; 7) Able to complete rs-fMRI examination during the menstrual period/follicular phase; 8) Voluntarily signed informed consent form and able to cooperate with all research tests and evaluations. Untreated PCOS patient group 1) Age 18-40 years old, female; 2) Met the Rotterdam PCOS diagnostic criteria in 2003 (satisfying 2 out of the following 3 items, and excluding other diseases causing hyperandrogenism and ovulation disorders): oligoovulation or no ovulation; clinical or biochemical hyperandrogenic manifestations; pelvic ultrasound indicating polycystic ovarian changes; 3) At least 3 months without any treatment for PCOS, including electroacupuncture, acupuncture, oral contraceptives, progestogens, ovulation-promoting drugs, traditional Chinese medicine, etc.; 4) Able to complete rs-fMRI examination during the menstrual period/follicular phase; 5) Voluntarily signed informed consent form and able to cooperate with all research tests and evaluations. Electroacupuncture treatment group for PCOS patients (PCOS + EA) 1) Age 18-40 years old, female, meeting the above PCOS diagnostic criteria; 2) Completed at least 24 standardized electroacupuncture treatments, with the treatment plan being unified: select classic acupoints such as Guanyuan, Zhongji, Sanyinjiao, Zusanli, Taiyang, etc., using sparse-dense waves (2/100 Hz), with the current intensity determined by the subject's tolerance, at least 2 treatments per week, each 20-30 minutes; 3) Electroacupuncture treatment compliance = 80% (actual treatment times / planned treatment times = 80%); 4) No combination of other treatments for PCOS during the treatment period; 4) Able to complete rs-fMRI examination during the menstrual period/follicular phase; 5) Voluntarily signed informed consent form and able to cooperate with all research tests and evaluations.

Exclusion criteria

Exclusion criteria: 1) Those with severe organic diseases of the heart, liver, kidney, cerebrovascular system, blood system, etc.; 2) Those with severe mental disorders such as schizophrenia, bipolar disorder, severe anxiety and depression; 3) Those with a history of central nervous system diseases such as brain trauma, epilepsy, brain tumor, multiple sclerosis, etc.; 4) Those with contraindications for rs-fMRI testing (such as having metal implants in the body, pacemakers, claustrophobia, etc.) or unable to cooperate in completing brain function testing; 5) Pregnant or lactating women, or those with a planned pregnancy within the last 3 months; 6) Those who have used drugs affecting neurotransmitters and hormone levels within the last 3 months, such as glucocorticoids, antipsychotics, antidepressants, contraceptives, etc.; 7) Those with a history of drug abuse, alcoholism, or smoking (smoking = 5 cigarettes per day, drinking = 3 times per week); 8) Those who cannot complete rs-fMRI testing during the menstrual period/follicular phase; 9) Those who refuse to sign the informed consent form, or those who cannot cooperate in completing the research assessment due to cognitive or communication disorders; 10) Those who have participated in other clinical trials within the last 1 month.

Design outcomes

Primary

MeasureTime frame
Brain function indicators;

Secondary

MeasureTime frame
Clinical parameters;Psychological state indicators;

Countries

China

Contacts

Public ContactGui Juan

Renmin Hospital of Wuhan University

514325204@qq.com13971277429

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Aug 10, 2026